About 15,230 results

ALLMedicine™ Vasculitis Center

Research & Reviews  5,351 results

Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculit...
Rheumatology (Oxford, England); Ahn SS, Ha JW et. al.

Jul 29th, 2021 - To investigate the significance of rheumatoid factor (RF) positivity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) patients. AAV patients were divided into groups as follows: RF (+)/ANCA (+) (n = 94), RF (-)/ANCA (+) (n...

Epidemiology of Takayasu arteritis in Shanghai: A hospital-based study and systematic r...
International Journal of Rheumatic Diseases; Sun Y, Yin MM et. al.

Jul 28th, 2021 - Takayasu arteritis (TAK) is a rare large vessel vasculitis, and epidemiological data on TAK are lacking in China. Thus, we designed this study to estimate the TAK prevalence and incidence in residential Shanghai, China. Data on diagnosed TAK cases...

Large-vessel vasculitis with persistent exertional dyspnea in a 75-year-old woman.
https://doi.org/10.1007/s12350-021-02753-0 10.1093/ehjci/jew017
Journal of Nuclear Cardiology : Official Publication of T... Miura S, Naya M et. al.

Jul 28th, 2021 - Large-vessel vasculitis with persistent exertional dyspnea in a 75-year-old woman.|2021|Miura S,Naya M,Manabe O,Yamashita T,|

Coexistence of Takayasu arteritis and chronic myeloid leukemia: Coincidental or paraneo...
International Journal of Rheumatic Diseases; Yuce Inel T, Gulcu A et. al.

Jul 27th, 2021 - Vasculitis may rarely be seen in the course of myeloproliferative neoplasms (MPN). In vasculitis associated with hematological diseases, mostly small- and medium-vessel involvement is expected, aortitis is very rare. It is not exactly known whethe...

see more →

Guidelines  9 results

Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tuber...
Ophthalmology Agrawal R, Testi I et. al.

Jul 1st, 2020 - The Collaborative Ocular Tuberculosis Study (COTS), supported by the International Ocular Inflammation Society, International Uveitis Study Group, and Foster Ocular Immunological Society, set up an international, expert-led consensus project to de...

JCS 2017 Guideline on Management of Vasculitis Syndrome - Digest Version.
Circulation Journal : Official Journal of the Japanese Ci... Isobe M, Amano K et. al.

Jan 21st, 2020 - JCS 2017 Guideline on Management of Vasculitis Syndrome - Digest Version.|2020|Isobe M,Amano K,Arimura Y,Ishizu A,Ito S,|standards,standards,standards,diagnosis,epidemiology,physiopathology,therapy,

2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Annals of the Rheumatic Diseases; Hellmich B, Agueda A et. al.

Jul 5th, 2019 - Since the publication of the European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis (LVV) in 2009, several relevant randomised clinical trials and cohort analyses have been published, which have th...

European consensus-based recommendations for diagnosis and treatment of immunoglobulin ...
Rheumatology (Oxford, England); Ozen S, Marks SD et. al.

Mar 18th, 2019 - IgA vasculitis (IgAV, formerly known as Henoch-Schönlein purpura) is the most common cause of systemic vasculitis in childhood. To date, there are no internationally agreed, evidence-based guidelines concerning the appropriate diagnosis and treatm...

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statem...
Circulation McCrindle BW, Rowley AH et. al.

Mar 31st, 2017 - Kawasaki disease is an acute vasculitis of childhood that leads to coronary artery aneurysms in ≈25% of untreated cases. It has been reported worldwide and is the leading cause of acquired heart disease in children in developed countries. To revis...

see more →

Drugs  147 results see all →

Clinicaltrials.gov  101 results

Vasculitis Pregnancy Registry

Mar 24th, 2020 - The study will consist of several on-line surveys to assess each woman's vasculitis severity, pregnancy-related experiences, and pregnancy outcomes. Participants will be asked to complete questionnaires at study entry, during the second trimester,...

Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

Mar 23rd, 2020 - ANCA associated vasculitis are a rare group of diseases and potentially life-threatening inflammatory conditions. There is an urgent need to describe prognostic factors and to discover new therapeutic pathways. Soluble CD95-L is a cleaved part of ...

One-Time DNA Study for Vasculitis

Mar 23rd, 2020 - The systemic vasculitides comprise several inflammatory diseases of blood vessels, usually arteries, which may cause systemic, multi-organ disease that can result in substantial morbidity and increased mortality. Each type of vasculitis is a rare ...

FDG-PET Imaging in Complicated Diabetic Foot

Mar 17th, 2020 - FDG-PET imaging is a promising imaging technique, which has the potential to overcome many of the shortcomings mentioned previously with regard to radiologic and scintigraphic methodologies. FDG is a diagnostic tracer utilized to measure the metab...

Safety and Efficacy Study of IFX-1 in add-on to Standard of Care in Granulomatosis With Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

Mar 3rd, 2020 - Granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) are related systemic v anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a potentially life-threatening disease. GPA is a necrotizing vasculitis predo...

see more →

News  469 results

Pharmacovigilance Data Implicate Three New Drugs in ANCA-Associated Vasculitis

Jul 16th, 2021 - The overactive bladder treatment mirabegron (Myrbetriq) is one of three new drugs to be linked to cases of drug-associated antineutrophil cytoplasmic antibody–associated vasculitis (DA-AAV) according to pharmacovigilance data. The other two drugs ...

New ACR Guidelines Give Advice on Six Forms of Vasculitis

Jul 15th, 2021 - Three new guidelines from the American College of Rheumatology, in partnership with the Vasculitis Foundation, offer evidence-based recommendations for managing and treating six different forms of systemic vasculitis. Dr Sharon Chung "It's not unu...

Despite Risks, Switch to Brolucizumab Might Help Some With Wet AMD

Jun 1st, 2021 - NEW YORK (Reuters Health) - Patients with recalcitrant neovascular age-related macular degeneration (nAMD) who switched to brolucizumab from another anti-VEGF agent showed signs of improved vision in a single-center, retrospective study. The study...

Lower Glucocorticoid Dose Proves Effective for New-Onset ANCA-Associated Vasculitis

Jun 1st, 2021 - A reduced dose of prednisolone plus rituximab was as effective as a conventionally high dose in treating patients with newly diagnosed antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis, according to a new Japanese study, along with ...

FDA Panel Narrowly Backs Avacopan Approval

May 7th, 2021 - A panel of federal advisers on May 6 lent support to the ChemoCentryx bid for approval of avacopan for a rare and serious autoimmune condition. But they also flagged concerns about both the evidence supporting claims of a benefit for this experime...

see more →

Patient Education  15 results see all →